Population pharmacokinetic modeling of motesanib and its active metabolite, M4, in cancer patients

E-ISSN： 2160-7648|4|6|463-472

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.4, Iss.6, 2015-11, pp. : 463-472

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of a Population Pharmacokinetic Model for Atorvastatin Acid and Its Lactone Metabolite

By Narwal Rajesh

Clinical Pharmacokinetics, Vol. 49, Iss. 10, 2010-10 ,pp. : 693-702

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics of Itraconazole and its Active Metabolite Hydroxy-Itraconazole in Paediatric Cystic Fibrosis and Bone Marrow Transplant Patients

By Hennig Stefanie Wainwright Claire E. Bell Scott C. Miller Hugh Friberg Lena E. Charles Bruce G.

Clinical Pharmacokinetics, Vol. 45, Iss. 11, 2006-01 ,pp. : 1099-1114

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics of Gemcitabine and Its Metabolite in Japanese Cancer Patients: Impact of Genetic Polymorphisms

By Sugiyama Emiko Kaniwa Nahoko Kim Su-Ryang

Clinical Pharmacokinetics, Vol. 49, Iss. 8, 2010-08 ,pp. : 549-558

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetic Modeling of Subcutaneously Administered Etanercept in Patients with Psoriasis

By Nestorov Ivan Zitnik Ralph Ludden Thomas

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 31, Iss. 6, 2004-12 ,pp. : 463-490

Springer Publishing Company

Access to resources Recommend Favorite

Population Pharmacokinetic Meta-Analysis of Trabectedin (ET-743, Yondelis ® ) in Cancer Patients

By Juan Jose Perez-Ruixo Zannikos Peter

Clinical Pharmacokinetics, Vol. 46, Iss. 10, 2007-01 ,pp. : 867-884

Adis International

Access to resources Recommend Favorite